Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. The company is headquartered in Melbourne, Victoria and currently employs 58 full-time employees. The firm is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. The firm offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The firm has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The firm's segments include EasyDNA and AffinityDNA. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses.
Follow-Up Questions
GNTLF 주식의 가격 성능은 어떻습니까?
GNTLF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Genetic Technologies Ltd의 주요 사업 주제나 업종은 무엇입니까?
Genetic Technologies Ltd은 Life Sciences Tools & Services 업종에 속하며, 해당 부문은 Health Care입니다
